02/13/2025
2:56 PM | BML Investment Partners, L.P. (Filed by)
Eliem Therapeutics (Subject)
Climb Bio, Inc. (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:15 PM | Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:08 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form EFFECT | |
11/14/2024
8:29 AM | Eliem Therapeutics (Subject)
Climb Bio, Inc. (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
3:51 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
6:08 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
8:53 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ELYM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/27/2024
4:21 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
4:47 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:40 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Kaplan Brett (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/26/2024
6:07 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:23 PM | AI ETI LLC (Filed by)
Eliem Therapeutics (Subject)
Eliem Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
08/14/2024
5:06 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:10 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
11:15 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form EFFECT | |
07/23/2024
4:04 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:31 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 424B3 | |
07/19/2024
10:12 AM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
5:11 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:14 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
7:45 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:46 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:42 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:38 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/02/2024
3:39 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/02/2024
3:01 PM | Deep Track Capital, LP (Filed by)
Eliem Therapeutics (Subject)
Eliem Therapeutics, Inc. (Subject)
| Form SC 13G | |
07/01/2024
8:28 PM | Eliem Therapeutics (Subject)
Eliem Therapeutics, Inc. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
07/01/2024
8:29 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:09 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Levin Andrew David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:14 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:23 PM | Dunn Judith (Reporting)
Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:26 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Rosenberg Adam Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:09 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Ratcliffe Liam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:13 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Tate Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
6:01 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Thomas Stephen Basil (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
6:03 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Thomas Stephen Basil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
America cannot power AI (Ad) There’s a fatal flaw at the heart of the AI revolution…
With AI continuing to explode in popularity, tech companies are all scrambling to build hundreds of new mega data centers to keep up with the demand for training and using new AI models.
But that’s where the problem is. I call it “The AI Keystone”. Go here now to get the name of the company, along with my full investigation into why it’s the most |
06/27/2024
6:05 PM | Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:22 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
3:23 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
1:57 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:41 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:42 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form DEFA14A | |
06/04/2024
7:00 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form DEFM14A | |
06/04/2024
7:05 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form ARS | |
05/15/2024
5:19 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
5:01 PM | Affinity Asset Advisors, LLC (Filed by)
Eliem Therapeutics (Subject)
Eliem Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/12/2024
5:52 PM | Eliem Therapeutics (Subject)
Eliem Therapeutics, Inc. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/11/2024
7:01 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:10 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form DEFA14A | |
04/08/2024
4:33 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:05 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
3:33 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
10:07 AM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Morisset Valerie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
